SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis

NCT00155116CI-TRIAL-00000214unknownClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

To evaluate the correlation between SERPIN D1 expression in clinical specimen (including surgical specimen and blood sample) and lung cancer metastasis.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Non-Small Cell Lung Cancer	Lung Non-Small Cell Carcinoma	ALIAS	0.90

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years

Show eligibility criteria text

Inclusion Criteria:

* non-small cell lung cancer patient, pathological proved

Exclusion Criteria:

\-

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Oct 1, 2004
Primary completion: —
Completion: Dec 1, 2006
First posted: Sep 12, 2005
Last update posted: Nov 23, 2005
Enrollment: 100
Lead sponsor: National Taiwan University Hospital OTHER

Data updated 22 days agoSource updated Nov 23, 2005source: clinicaltrials

Locations

Locations by country (1)

Country	Sites	Recruiting
Taiwan	1	1

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.